Testing Potential Synergistic Effects of Albuterol and Caffeine on Metabolic Rate
Public ClinicalTrials.gov record NCT02135965. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Testing Potential Synergistic Effects of Albuterol and Caffeine on Metabolic Rate.
Study identification
- NCT ID
- NCT02135965
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Early Phase 1
- Lead sponsor
- Pennington Biomedical Research Center
- Other
- Enrollment
- 8 participants
Conditions and interventions
Conditions
Interventions
- 2mg of Albuterol Drug
- 4mg of Albuterol Drug
- 100mg of Caffeine Drug
- 200mg of Caffeine Drug
- Albuterol 2mg & Caffeine 100mg Drug
- Albuterol 2mg and Caffeine 200mg Drug
- Albuterol 4mg and Caffeine 100mg Drug
- Albuterol 4mg and Caffeine 200mg Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 50 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2009
- Primary completion
- Jul 31, 2011
- Completion
- Jul 31, 2011
- Last update posted
- Dec 17, 2015
2009 – 2011
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pennington Biomedical Research Center | Baton Rouge | Louisiana | 70808 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02135965, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 17, 2015 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02135965 live on ClinicalTrials.gov.